To escalate the war on cancer, Sutro Biopharma has launched a public offering with the goal of raising $75 million. These proceeds are set to bolster Sutro's efforts in creating cutting-edge antibody-drug conjugates (ADCs), which stand at the forefront of its cancer treatment research. By
The Imperative for High-Quality Control in Biomanufacturing In the ever-evolving landscape of biopharmaceutical manufacturing, the imperative for maintaining high-quality control measures is unarguable. With the introduction of complex biological materials into gene therapies and vaccine
At the recent BPI Europe 2024 conference, a landmark discussion led by Uwe Buecheler from Boehringer Ingelheim marked the dawn of a new chapter in biopharmaceuticals. Described as the 'third wave' of biologics, it signifies an era brimming with groundbreaking therapeutic innovations that
The swift advancement of technology has raised significant concerns about the protection of personal data. In response, the United States is seeing an increasingly diverse collection of state-enacted privacy laws. With federal action lagging, individual states are crafting their own regulatory
The pursuit of understanding the medical benefits of cannabis continues to evolve as researchers like those at MMJ BioPharma Cultivation Inc. face significant bureaucratic resistance, particularly from federal institutions such as the DEA. The company’s recent lawsuit highlights the extensive c
The realm of antibiotic therapy is witnessing a remarkable transformation with the UK's MHRA's endorsement of Exblifep, a novel medical intervention for the management of sophisticated urinary tract infections (UTIs) and select instances of pneumonia. Originating from Advanz Pharma's
The intersection of social media and pharmaceutical regulation hit a flashpoint when Pfizer, a leading company in COVID-19 vaccine development, faced repercussions for a seemingly innocuous tweet. While social networks provide a powerful platform for sharing news and advancements, they also raise
Revolutionizing Point of Care Diagnostics Artificial Intelligence (AI) is rapidly transforming the medical field, with one of its most significant impacts being in the domain of cardiac imaging. The integration of AI technology with handheld ultrasound devices is enabling clinicians to perform
Genetic Link to B-cell Acute Lymphoblastic Leukemia The Prevalence in Hispanic/Latino Children A pioneering study by the Dana-Farber Cancer Institute has unveiled insights into the increased prevalence of B-cell acute lymphoblastic leukemia (ALL) in Hispanic/Latino children. Employing a genome-wide
The University of Wollongong statisticians are revolutionizing agricultural biotech with their DWReml software. This cutting-edge tool excels in analyzing large-scale, complex data from crop breeding experiments that span many years and environments. DWReml meets the modern grower's need for
